BILL • US HOUSE
The CLEAR LABELS Act requires drug labels to disclose the original manufacturer and supply chain details for finished drugs and APIs, with access via a portal or paper upon request
No documents available
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
No votes available
We're glad to see you!
New to WeVote? Claim your Voter Profile now!
Are you an elected rep? Claim account
Join thousands of verified voters to weigh in.
Already have an account? Log in
Are you an elected rep? Claim account
No worries! Enter your email and we'll send you reset instructions.
Remember your password? Back to Login
Your email address has not been confirmed yet. Please check your inbox or request a new confirmation link below.
Didn't receive the email?
Already confirmed? Back to Login
You need to take action to continue.
You're currently in
Joining this room will disconnect you from the current one.
The meeting has ended.
